Algernon Pharmaceuticals's total assets for Q4 2025 were C$4.88M, a decrease of -1.04% from the previous quarter. AGNPF total liabilities were C$2.18M for the fiscal quarter, a -10.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.